Helicobacter pylori (H. pylori) is a gram-negative bacterium that specifically colonizes the gastric epithelium causing many complications. The link between H. pylori infection and diabetes mellitus (DM) remains controversial. This study was conducted to determine the frequency of H. pylori infection among a group of subjects with DM and to compare it with that of an age and sex-matched group of non-diabetic subjects.
Introduction
elicobacter pylori (H. pylori) is a gram negative, spiral shaped pathogenic bacterium that specifically colonizes the gastric epithelium causing chronic gastritis, peptic ulcer disease, and/or gastric malignancy 1, 2 . H. pylori is mainly acquired in childhood by the fecooral, oro-oral or gastro-oral routes 3 . It has been estimated that up to half of the world's population harbor the infection in their stomach 4 . The developing world has a higher prevalence rate of infection than the developed world, and it has associated with both gastrointestinal and extra-intestinal complications 5 . H. pylori infection may have an impact on cardiovascular conditions, insulin resistance, and metabolic syndrome potentially mediated by elevations in inflammatory markers such as C-reactive protein (CRP) and Interlukin-6 (IL-6) 6 . Elevated levels of inflammatory cytokines may lead to phosphorylation of serine residues on the insulin receptor substrate, which prevents its interaction with insulin receptors, and then inhibits insulin action 7 . Mammalian stomach produces leptin and ghrelin, two hormones involved in energy homeostasis and whose interactions affect obesity, insulin sensitivity, and glucose homeostasis. Increasing evidence indicates that H. pylori is involved in the regulation of these hormones 8 . The link between H. pylori infection and diabetes remains controversial, as some studies indicate a higher prevalence of infection in diabetic patients 9, 10 , while others report no difference 11, 12 20 and increased susceptibility of pathogens as they regularly attend hospital settings 21 . However, there are also indications that H. pylori infection may contribute to the development of diabetes. Whereas insulin insensitivity is an early phenomenon, pancreatic β-cell function declines gradually over time before the onset of clinical hyperglycemia, the result of many factors that can be influenced by infection, such as insulin resistance (IR), glucotoxicity, lipotoxicity, β-cell dysfunction, chronic inflammation, and genetic and epigenetic factors 22, 23 . This study aims to determine the frequency of H. pylori infection among a group of subjects with DM and to compare it with that of an age and sexmatched group of non-diabetic subjects.
Patients and Methods
This case control study was conducted in Al-Sadr Teaching Hospital, Basrah, Southern Iraq from January 2013 to September 2014 on 200 subjects aged ≥40 years who were divided into two groups: Group 1: consisted of 100 subjects known to have DM and on anti-diabetic medications (81 on oral and 19 on insulin), Group 2: consisted of 100 nondiabetic subjects, for whom samples of venous blood were sent for fasting blood sugar to rule out the possibility of undiagnosed DM by readings <7 mmol/L according to American Diabetic Association 24 . All subjects were required to submit fresh stool samples which were tested for evidence of H. pylori infection by stool antigen positivity with the immunoassay-based Rapid Strip HpSATM according to the manufacturer's instructions (from CTK Biotech, Inc), since it has high sensitivity (94%) and specificity (94%) and is potentially very helpful in diagnosing active and repeated H. pylori infection 25 . Glycated haemoglobin ( HbA1c) was ordered for all diabetic subjects, and according to the result, they were subdivided into 3 groups : group (A) with HbA1c<7, group (B) with HbA1c 7-10 and group (C) with HbA1c>10. The frequency of H. pylori infection was then measured among each group.
Exclusion criteria: 1-Newly diagnosed cases of DM and those with a history of less than 2 years duration. 2-Subjects on antibiotics and/or proton pump inhibitors. 3-Subjects with GIT bleeding. 4-Subjects with haemoglobinopathies. 5-Subjects with a history of renal failure, chronic liver disease, malignant disease or on immunosuppressant agents. Statistical analysis was done by using the SPSS V 19 multilingual software. P value less than 0.05 was considered to be significant.
Results
Both 2 groups (diabetic and nondiabetic) were matched in view of age and gender as there was no significant statistical difference. The mean age±SD of group 1 subjects was 55.7±10.2 years, while that of group 2 subjects was 57.6±10.9 years. The P value was 0.203 [ Table I ]. HpSA positive was 10.18 (±0.28)%, while that for those with HpSA negative was 8.5(±2.09)%. This difference was found to be statistically significant (P value<0.001).
Furthermore, by subdividing the diabetic subjects into group A , B and C depending on HbA1c level, it was found that the percentage of infected subjects with H. pylori was the highest (73%) among group C ( HbA1c>0), (31%) among group B (HbA1c 7-10), and the lowest (25%) among groupA (HbA1c<7), as demonstrated in figure 1.
Figure 1: Percentage of HpSA positive subjects among each HbA1c group
In addition, H. pylori infection was found to be significantly higher among those with long duration DM (>5 years) as compared with those with short duration DM (2-5 years), as demonstrated in table III. Among the studied population, the mean age for subjects with HpSA positive was 57.9 (±11.1) years, while that for those with HpSA negative was 56.07 (±10.3) years. This difference found to be statistically not significant (P value =0.24). Twenty five from 88 males (28.4%) in the studied population were HpSA positive, while 43 from 112 females (38.3%) were HpSA positive. This difference was found to be statistically not significant. [ Table V ]. 27, 28 . In contrast to these findings Gillum et al., found that H. pylori infection status was not significantly associated with HbA1C in men aged 40-70 years with or without history of type 2 diabetes 29 . Furthermore, among diabetic subjects, group C with HbA1c >10% was found to have the highest frequency of H. pylori infection in comparison to group A and B. This finding made us to ask weather H. pylori can directly or indirectly increase levels of HbA1c. We now know that H. pylori plays a role in the regulation of leptin and ghrelin, which are central to energy homeostasis and metabolism, and whose interactions can affect obesity, insulin sensitivity, and glucose homeostasis 8, [30] [31] [32] .
H. pylori infection was found to be significantly higher among those with long duration DM (>5 years) as compared with those with short duration DM(2-5 years). This can be explained as the longer the duration of hyperglycemia, the more is the risk of chronic complication 24 . The mean age of patients with H. pylori infection was 57.9 years, while the mean age of those without infection was 56.07 years. The difference was found to be not significant. In another study the mean age of diabetic patients with H. pylori infection was 60 years 14 . However, a study by Sargýn et al. showed that the mean age was 56 years 33 . Most of the H. pylori related diseases are associated with male gender, the role of gender as a risk factor for H. pylori infection is still debated. This study showed that 25/88 (28.4%) of males in the studied populations were infected with H. pylori, while 43/112 (38.3%) of females were infected. However, this difference was found not to be significant. Another study conducted by Catherine showed that males were predominant to have H. pylori infection in adults as a global and homogeneous phenomenon 34 . On the other hand, in another study the H. pylori infected females were predominant as compared to males 35 . Conclusion: The present study suggests that diabetic patients are at more risk for H. Pylori infection in comparison to non-diabetic population. This association is found to be higher in those with long duration of DM and those with poor glycemic control.
